genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2020
Remdesivir
Coronavirus
Promising Broad-Spectrum Antiviral Emerges for COVID-19 from Veteran SARS Lab
Coronavirus
Assessing Coronavirus Impact on Wall Street
Coronavirus
MERS Coronavirus Disease Blocked by Remdesivir in Monkeys
Bioprocessing
Coronavirus: China’s BrightGene Manufactures APIs of Gilead’s Remdesivir
Coronavirus
Coronavirus: Gilead’s Remdesivir Begins Trials as Researchers Publish Positive In Vitro Results
Coronavirus
Gilead Partnering with China on Trial of Remdesivir as Coronavirus Treatment
1
2
Page 2 of 2
Scroll Up
Scroll Up
